HomeSOFW • TLV
Sofwave Medical Ltd
ILA 2,009.00
May 15, 5:24:24 PM GMT+3 · ILA · TLV · Disclaimer
StockIL listed security
Previous close
ILA 2,042.00
Day range
ILA 2,009.00 - ILA 2,082.00
Year range
ILA 1,300.00 - ILA 2,107.00
Market cap
706.21M ILS
Avg Volume
42.38K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
16.67M26.45%
Operating expense
13.68M25.82%
Net income
-1.11M-13.12%
Net profit margin
-6.6710.59%
Earnings per share
EBITDA
-563.00K-2.18%
Effective tax rate
5.12%
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
20.40M-11.73%
Total assets
42.06M1.69%
Total liabilities
17.76M15.05%
Total equity
24.29M
Shares outstanding
34.97M
Price to book
29.59
Return on assets
-5.62%
Return on capital
-9.25%
Net change in cash
(USD)Mar 2025Y/Y change
Net income
-1.11M-13.12%
Cash from operations
-1.31M-3.90%
Cash from investing
-407.00K-650.00%
Cash from financing
-65.00K58.33%
Net change in cash
-1.74M-32.29%
Free cash flow
-1.50M-188.83%
About
Sofwave Medical is an Israeli aesthetic medicine company based in Israel with headquarters in California, United States. It is publicly traded, listed on the Tel Aviv Stock Exchange. Sofwave develops an ultrasound system for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles and for short term improvement in the appearance of cellulite. Wikipedia
Founded
2015
Employees
126
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu